23:29 , Oct 6, 2017 |  BioCentury  |  Finance

High as a Kite

The acquisition of Kite Pharma Inc. by Gilead Sciences Inc. turned what would have been a flattish quarter into another period of outperformance, and relieved the cash constraints that could have prevented specialists from continuing...
19:53 , Sep 22, 2017 |  BC Week In Review  |  Financial News

Celcuity raises $22.8M in IPO

On Sept. 20, cancer diagnostic company Celcuity Inc. (NASDAQ:CELC) raised $22.8 million through the sale of 2.4 million shares at $9.50 in an IPO underwritten by Craig-Hallum Capital. Celcuity Inc. (NASDAQ:CELC), Minneapolis, Minn. ...